世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034041

分子診断のフランス市場(2023年)- 2022年のサプライヤーシェア、機器設置台数、および戦略、2022年から2027年までの個々の感染症、遺伝子疾患、癌、法医学、および父子鑑定に対する検査件数と売上セグメント予測

VPGMarketResearch

2023 France Molecular Diagnostics Market: 2022 Supplier Shares, Instrumentation Installed Base and Strategies, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

発刊日 2023/01/23

言語英語

体裁PDF

ライセンス/価格

0000034041

Local PDF
Global PDF

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

このデータベースは、2022 年のサプライヤーのシェア、2022 年から 2027 年の感染症、遺伝子疾患、がん診断、法医学、および父子鑑定のアプリケーションに対する検査件数と売上予測、ならびに主要検査の新しい技術や製品を開発または販売している企業の包括的なリストを提供します。

調査範囲

  • 調査企業
    ➣ Abbott
    ➣ Agilent Technologies
    ➣ Applied Gene Technologies
    ➣ Arca Biopharma
    ➣ Beckman Coulter/Danaher/Cepheid
    ➣ Becton Dickinson
    ➣ Biokit
    ➣ bioMerieux
    ➣ Bio-Rad
    ➣ Decode Genetics
    ➣ Diasorin
    ➣ 栄研化学(Eiken Chemical)
    ➣ Elitech Group
    ➣ Enzo Biochem
    ➣ Exact Sciences
    ➣ 富士レビオ(Fujirebio)
    ➣ Grifols
    ➣ Hologic/Gen-Probe
    ➣ Illumina
    ➣ LabCorp/Sequenom
    ➣ Leica Biosystems/Kreatech
    ➣ Li-Cor Biosciences
    ➣ Myriad Genetics
    ➣ Proteome Sciences
    ➣ Qiagen
    ➣ Quest Diagnostics
    ➣ QuidelOrtho
    ➣ Roche
    ➣ 島津製作所(Shimadzu)
    ➣ Siemens Healthineers
    ➣ タカラバイオ(Takara Bio)
    ➣ Tecan Group
    ➣ Thermo Fisher

レポート詳細

目次

List of Tables
Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct
Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular
Diagnostic Tests For Genetic Diseases
France
Molecular Diagnostics Test Volume And Sales
By Major Application
France
Laboratories Performing DNA Sequencing
By Market Segment
France
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
France
Molecular Diagnostics Test Volume
By Major Application
France
Major Infectious Disease Test Volume by Assay
France
Major Infectious Disease Test Volume by Method
France
Molecular Diagnostics Market
By Major Application
France
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers
France
Major Infectious Disease Diagnostics Market by Assay
France
AIDS Testing Market
Estimated Sales by Major Supplier
France
Adenovirus Testing Market
Estimated Sales by Major Supplier
France
Chlamydia Testing Market
Estimated Sales by Major Supplier
France
CMV Testing Market
Estimated Sales by Major Supplier
France
Gonorrhea Testing Market
Estimated Sales by Major Supplier
France
Hepatitis Testing Market
Estimated Sales by Major Supplier
France
Hepatitis C Testing Market
Estimated Sales by Major Supplier
France
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier
France
Herpes Testing Market
Estimated Sales by Major Supplier
France
Influenza Testing Market
Estimated Sales by Major Supplier
France
Meningitis Testing Market
Estimated Sales by Major Supplier
France
Mycoplasma Testing Market
Estimated Sales by Major Supplier
France
RSV Testing Market
Estimated Sales by Major Supplier
France
Shigella Testing Market
Estimated Sales by Major Supplier

この商品のレポートナンバー

0000034041

最近見たレポート

38カ国における分子診断のヨーロッパ市場(2023年)- 2022年の国別のサプライヤーシェア、機器設置台数、および戦略、2022年から2027年までの個々の感染症、遺伝子疾患、癌、法医学、および父子鑑定に対する検査件数と売上セグメント予測

2023 Europe Molecular Diagnostics Market in 38 Countries: 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

2023/01/23

14,500 USD

分子診断のイギリス市場(2023年)- 2022年のサプライヤーシェア、機器設置台数、および戦略、2022年から2027年までの個々の感染症、遺伝子疾患、癌、法医学、および父子鑑定に対する検査件数と売上セグメント予測

2023 U.K. Molecular Diagnostics Market: 2022 Supplier Shares, Instrumentation Installed Base and Strategies, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

2023/01/23

1,850 USD

分子診断のロシア市場(2023年)- 2022年のサプライヤーシェア、機器設置台数、および戦略、2022年から2027年までの個々の感染症、遺伝子疾患、癌、法医学、および父子鑑定に対する検査件数と売上セグメント予測

2023 Russia Molecular Diagnostics Market: 2022 Supplier Shares, Instrumentation Installed Base and Strategies, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

2023/01/23

1,450 USD

分子診断の中国市場(2023年)- 2022年のサプライヤーシェア、機器設置台数、および戦略、2022年から2027年までの個々の感染症、遺伝子疾患、癌、法医学、および父子鑑定に対する検査件数と売上セグメント予測

2023 China Molecular Diagnostics Market: 2022 Supplier Shares, Instrumentation Installed Base and Strategies, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

2023/01/23

1,450 USD

分析機器市場規模、シェア、動向分析レポート、予測2023-2030

Analytical Instrumentation Market Size, Share & Trends Analysis Report 2023 - 2030

2023/01/01

5,950 USD

シンガポールの糖尿病装置および治療薬市場における投資機会 - 診断・モニタリング装置、治療薬、併用薬、投与経路、糖尿病のタイプ、流通チャネル、エンドユーザー、競合状況別の分析と市場規模 - 2025年第2四半期更新版

Singapore Diabetes Devices and Therapeutics Market Investment Opportunities - Analysis & Market Size by Diagnosis and Monitoring Devices, Therapeutics, Combination Drugs, Route of Administration, Type of Diabetes, Distribution Channels, End User, Competitive Landscape - Q2 2025 Update

2025/03/28

600 USD

TOP